CELLBN DAMAGE PRECIOUS SERUM (WORLDCOSTEC.CO.,LTD)
Welcome to the PulseAid listing for the CELLBN DAMAGE PRECIOUS SERUM drug offered from WORLDCOSTEC.CO.,LTD. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | WORLDCOSTEC.CO.,LTD |
NON-PROPRIETARY NAME: | Arbutin, Adenosine |
SUBSTANCE NAME: | ARBUTIN; ADENOSINE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2017-05-26 |
END MARKETING DATE: | 0000-00-00 |
CELLBN DAMAGE PRECIOUS SERUM HUMAN OTC DRUG Details:
Item Description | CELLBN DAMAGE PRECIOUS SERUM from WORLDCOSTEC.CO.,LTD |
LABELER NAME: | WORLDCOSTEC.CO.,LTD |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1; .05(g/100mL; g/100mL) |
START MARKETING DATE: | 2017-05-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 71450-0005_50a0340e-2b14-6776-e054-00144ff88e88 |
PRODUCT NDC: | 71450-0005 |
APPLICATION NUMBER: | |
Other ARBUTIN; ADENOSINE Pharmaceutical Manufacturers / Labelers: